Knowledgeable
Resources
playbooks· 8 June 2026· 9 min read

Why AMNOG is won or lost in the first 90 days

The dossier teams who win Zusatznutzen don't out-write everyone else. They out-sequence them.

Author
Charlie Brook
Chief Innovation Officer
The 90-day rule
Every AMNOG submission we have reverse-engineered that landed _erheblich_ or _beträchtlich_ had a stable evidence skeleton by day 30, a defended comparator by day 60, and a written reviewer-anticipation memo by day 90.
€312m
Median lost lifetime revenue when Zusatznutzen drops one tier
14 days
Average G-BA clarification window — you do not get a second one
73%
Of dossiers we audit cite a comparator the G-BA will reject on first read

Day 1–30: lock the evidence skeleton

Most teams open with the comparator debate. That is already too late. Day 1 is for the evidence skeleton: the exact PICO, the studies that will carry Module 4, and a one-page map of every claim you intend to make and the citation that defends it. If a claim does not have a source by day 30, it does not go in the dossier.

The old wayThe Knowledgeable way
Comparator workshop in week 6Comparator hypothesis in week 1, stress-tested against G-BA precedent in week 2
Evidence review handed to an external SR vendorLiving evidence map with every claim source-linked, refreshed nightly
Module 4 draft starts week 14Module 4 skeleton populated from day 1; only the narrative is written late

Day 31–60: defend the comparator

Your comparator choice is the single highest-leverage decision in the entire submission. Defend it in writing before week 9 — including a memo of the comparators the G-BA has accepted and rejected in adjacent indications over the last 36 months.

Three comparator traps
1) Picking the comparator your global team prefers, not the one G-BA precedent supports. 2) Treating zweckmäßige Vergleichstherapie as a labeling exercise instead of a precedent-driven argument. 3) Discovering on day 80 that your pivotal trial does not contain it.

Day 61–90: write the reviewer-anticipation memo

The reviewer-anticipation memo is the artefact most teams skip — and it is the one that converts a beträchtlich into a defensible erheblich. Walk through every weak link in your evidence chain, anticipate the G-BA question, and write the answer before they ask it.

Run your next AMNOG submission as a sprint

Knowledgeable compresses the 90-day sequence into a single workspace — evidence skeleton, comparator memo, and Module 4 skeleton, all source-linked.

See the AMNOG workspace